… pneumococcal vaccines was limited; therefore, we were not able to analyze the outcomes by
vaccine type. … , stroke, cardiovascular mortality may have affected our assessment on these …

… CV outcomes. According to our analysis the best population to investigate the effect of
pneumococcal vaccination on CV outcomes is subjects over 65 years with known cardiovascular …

… Studies had wide durations of follow-up, ranging from 90 days to several years, while the
definitions of the various cardiovascular outcomes varied from one study to another, posing a …

… vaccination and pneumococcal vaccination has been associated with improved cardiovascular
outcomes [8… with combined use of influenza and pneumococcal vaccination. Furthermore, …

… the impact of vaccination on all-cause mortality compared to no vaccination in this particular
… and meta-analysis of the impact of pneumococcal vaccination in the referred population. …

… (PPV) and a cardiovascular protective effect. However, … of studies on PPV and cardiovascular
outcomes. Medline, Embase … possibility that pneumococcal vaccination protects against …

… and the circulatory systems, influenza and pneumococcal vaccinations are recommended
in the prevention and treatment of cardiovascular diseases. The review summarizes the …

… , we hypothesized that pneumococcal vaccination would protect … study, pneumococcal
vaccination was not associated with a lower risk of myocardial infarction; however, the vaccination …

… and mortality in patients with cardiovascular disease. We assessed the effects of the influenza
vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease. …

… Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. … The
major strengths of this study were its population-based design and the validation of outcome …